Abgent

Abgent is a biotechnology company that specializes in the production of antibodies. The company is known for its innovative approaches to antibody production and its commitment to providing high-quality products for research and clinical applications.

History[edit | edit source]

Abgent was founded in the early 2000s with the goal of advancing the field of biotechnology through the development of novel antibody-based products. Since its inception, the company has grown to become a leading provider of antibodies for both research and clinical applications.

Products and Services[edit | edit source]

Abgent offers a wide range of products and services, including primary antibodies, secondary antibodies, peptide synthesis, and protein expression services. The company's primary antibodies are designed to target a variety of biological processes and diseases, including cancer, neurodegenerative diseases, and inflammatory diseases.

Abgent's secondary antibodies are designed to detect and quantify the presence of primary antibodies, providing a crucial tool for researchers in the field of immunology.

In addition to its antibody products, Abgent also offers peptide synthesis and protein expression services. These services allow researchers to produce custom peptides and proteins for use in their experiments.

Research and Development[edit | edit source]

Abgent is committed to advancing the field of biotechnology through its research and development efforts. The company's R&D team is constantly working to develop new antibodies and improve existing ones. This commitment to innovation has resulted in a number of breakthroughs in the field of antibody production.